Anirudh Sreekrishnan1, Audrey C Leasure2, Fu-Dong Shi3, David Y Hwang2, Joseph L Schindler2, Nils H Petersen2, Emily J Gilmore2, Hooman Kamel4, Lauren H Sansing2, David M Greer2, Kevin N Sheth2. 1. Division of Neurocritical Care and Emergency Neurology, Department of Neurology, Yale University School of Medicine, 15 York St, LCI 1003, New Haven, CT, 06510, USA. anirudh.sreekrishnan@yale.edu. 2. Division of Neurocritical Care and Emergency Neurology, Department of Neurology, Yale University School of Medicine, 15 York St, LCI 1003, New Haven, CT, 06510, USA. 3. Department of Neurology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA. 4. Department of Neurology, Weill Cornell Medical College, New York, NY, USA.
Abstract
BACKGROUND AND PURPOSE: As survival rates have increased for intracerebral hemorrhage (ICH) patients, there is limited information regarding recovery beyond 3-6 months. This study was conducted to examine recovery curves using the modified Rankin Scale (mRS) and Barthel Index (BI) up to 12 months post-injury. METHODS: We prospectively enrolled 173 patients admitted with ICH who were subsequently evaluated using the mRS and BI at discharge as well as 3, 6, and 12 months. Repeated measures nonparametric testing was conducted to assess functional trajectories across time. RESULTS: The mRS scores showed significant improvement between discharge (median 4) and 3 (median 4), 6 (median 4), and 12 months (median 3) (p values <0.001). However, the mRS scores did not differ between follow-up time-points (i.e., 3-6, 6-12 months). There was significant improvement in scores using the BI (p values <0.001), showing improvement between discharge (mean 43.0) and 3 (mean 73.0), 6 (mean 78.2), and 12 months (mean 83.4). Additionally, there were differences in the BI between 3 and 12 months (p = 0.013), as well as between 6 and 12 months (p = 0.025). CONCLUSIONS: The BI may be a more sensitive measure of long-term recovery post-injury than the mRS, which shows minimal improvement for some survivors after 3 months. BI scores indicate survivors continually improve till 12 months post-injury. These results may have implications for the prognostication of ICH and design of clinical trial outcome measures.
BACKGROUND AND PURPOSE: As survival rates have increased for intracerebral hemorrhage (ICH) patients, there is limited information regarding recovery beyond 3-6 months. This study was conducted to examine recovery curves using the modified Rankin Scale (mRS) and Barthel Index (BI) up to 12 months post-injury. METHODS: We prospectively enrolled 173 patients admitted with ICH who were subsequently evaluated using the mRS and BI at discharge as well as 3, 6, and 12 months. Repeated measures nonparametric testing was conducted to assess functional trajectories across time. RESULTS: The mRS scores showed significant improvement between discharge (median 4) and 3 (median 4), 6 (median 4), and 12 months (median 3) (p values <0.001). However, the mRS scores did not differ between follow-up time-points (i.e., 3-6, 6-12 months). There was significant improvement in scores using the BI (p values <0.001), showing improvement between discharge (mean 43.0) and 3 (mean 73.0), 6 (mean 78.2), and 12 months (mean 83.4). Additionally, there were differences in the BI between 3 and 12 months (p = 0.013), as well as between 6 and 12 months (p = 0.025). CONCLUSIONS: The BI may be a more sensitive measure of long-term recovery post-injury than the mRS, which shows minimal improvement for some survivors after 3 months. BI scores indicate survivors continually improve till 12 months post-injury. These results may have implications for the prognostication of ICH and design of clinical trial outcome measures.
Authors: Sebastian Urday; Lauren A Beslow; David W Goldstein; Anastasia Vashkevich; Alison M Ayres; Thomas W K Battey; Magdy H Selim; W Taylor Kimberly; Jonathan Rosand; Kevin N Sheth Journal: Stroke Date: 2015-02-26 Impact factor: 7.914
Authors: Christian Zweifel; Mira Katan; Philipp Schuetz; Andrea Ernst; Luigi Mariani; Beat Müller; Mirjam Christ-Crain Journal: Biomarkers Date: 2011-08-03 Impact factor: 2.658
Authors: Anirudh Sreekrishnan; Jennifer L Dearborn; David M Greer; Fu-Dong Shi; David Y Hwang; Audrey C Leasure; Sonya E Zhou; Emily J Gilmore; Charles C Matouk; Nils H Petersen; Lauren H Sansing; Kevin N Sheth Journal: Neurocrit Care Date: 2016-12 Impact factor: 3.210
Authors: J Claude Hemphill; Steven M Greenberg; Craig S Anderson; Kyra Becker; Bernard R Bendok; Mary Cushman; Gordon L Fung; Joshua N Goldstein; R Loch Macdonald; Pamela H Mitchell; Phillip A Scott; Magdy H Selim; Daniel Woo Journal: Stroke Date: 2015-05-28 Impact factor: 7.914
Authors: Christian Weimar; Tobias Kurth; Klaus Kraywinkel; Markus Wagner; Otto Busse; Roman Ludwig Haberl; Hans-Christoph Diener Journal: Stroke Date: 2002-08 Impact factor: 7.914
Authors: Mohammad Yousuf Rathor; Mohammad Fauzi Abdul Rani; A R Jamalludin; M Amran; T C A Shahrin; A Shah Journal: J Res Med Sci Date: 2012-11 Impact factor: 1.852
Authors: Magdy Selim; Lydia D Foster; Claudia S Moy; Guohua Xi; Michael D Hill; Lewis B Morgenstern; Steven M Greenberg; Michael L James; Vineeta Singh; Wayne M Clark; Casey Norton; Yuko Y Palesch; Sharon D Yeatts Journal: Lancet Neurol Date: 2019-03-18 Impact factor: 44.182
Authors: Floris H B M Schreuder; Mirre Scholte; Marike J Ulehake; Lotte Sondag; Maroeska M Rovers; Ruben Dammers; Catharina J M Klijn; Janneke P C Grutters Journal: Front Neurol Date: 2022-06-02 Impact factor: 4.086
Authors: Lydia Foster; Laura Robinson; Sharon D Yeatts; Robin A Conwit; Amjad Shehadah; Vasileios Lioutas; Magdy Selim Journal: Stroke Date: 2022-03-21 Impact factor: 10.170
Authors: Karen R Bottenfield; Bethany G E Bowley; Monica A Pessina; Maria Medalla; Douglas L Rosene; Tara L Moore Journal: Biol Sex Differ Date: 2021-10-09 Impact factor: 5.027
Authors: G Schwarz; B Kanber; F Prados; S Browning; R Simister; R Jäger; G Ambler; C A M Gandini Wheeler-Kingshott; David J Werring Journal: J Neurol Date: 2022-07-21 Impact factor: 6.682